Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.55.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.55.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.55.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.55.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LQ.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LQ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LQ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.62ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.62NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.55ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.55NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDKORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDKENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDKNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.54ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.54NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.120 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.120 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.120 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.120 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDK.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used